Angiodynamics, Inc.
Clinical trials sponsored by Angiodynamics, Inc., explained in plain language.
-
New device aims to safely remove deadly lung clots and recycle your own blood
Disease control Recruiting nowThis study tests a device that suctions blood clots from the lungs of people with a serious type of pulmonary embolism (a blood clot in the lung). The device also cleans and returns the removed blood back to the patient. The study will enroll 39 adults with acute intermediate-ris…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
New device aims to save limbs from amputation in severe artery disease trial
Disease control Recruiting nowThis study tests whether using a special device (Auryon Atherectomy System) along with standard balloon angioplasty is safer and more effective than balloon angioplasty alone for clearing blockages in the lower leg arteries. About 224 adults with severe limb-threatening blockages…
Phase: PHASE4 • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 26, 2026 06:43 UTC
-
New device aims to suck blood clots from lungs, potentially saving lives
Disease control Recruiting nowThis study tests a device called AlphaVac that is used to remove blood clots from the lungs in people with acute pulmonary embolism (a sudden blockage in the lung artery). About 256 adults with confirmed clots and signs of heart strain will be enrolled. The goal is to see if the …
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC